Alot will also weigh on which drugs/diseases Roche are seeking to target with these cell-penetrating peptides developed by PYC.
Hence the more significant role they play in their business the larger the projected royalties that will be in the spotlight.
It has all been withheld at this point.
Alot will also weigh on which drugs/diseases Roche are seeking...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $886.5M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.0¢ | $125.5K | 667.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11936 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 40292 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |